SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : FDA - Stocks close to approval: List them here

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IGUANA who wrote (57)3/8/1997 2:57:00 PM
From: Marc A. Goldfarb   of 83
 
Columbia Laboratories (COB) FDA approval expected in April or May for Crinone, a vaginally delivered sustained release natural progesterone.
It has many women's health indications including hormone replacement therapy. American Home Products, which owns and markets Premarin, the leading selling estrogen, has marketing rights to crinone.

Marc
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext